Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
This intro explains key decision criteria for choosing Pow over Pos, focusing on security, efficiency, and ecosystem maturity.
22,810 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Oil prices surged to a peak near $119 before pulling back, creating a volatile week for markets. Here are three takea...
Coherent is set to join the S&P 500 on March 23, 2026, triggering automatic purchases by index funds. The move follow...
Permanent Portfolio's Michael Cuggino argues Meta can invest heavily in AI without sacrificing profits. He emphasizes...
A leading advisory group signals a shift toward gold over silver as volatility spikes, citing safety, liquidity, and ...
Adobe shares have a tough year, yet JPMorgan sees upside. A $420 year-end target hinges on improving ARR, rising RPO,...
A senior macro investor warns that the global order is entering a perilous stage of the Big Cycle, likely to test mar...
Crypto swings may lift Coinbase, but the real upside comes from non crypto revenue streams. This guide explains why t...
Nasdaq CEO Adena Friedman frames AI as a growth catalyst for software, not a ruinous force. Her remarks come as softw...
As the bitcoin depot (btm) 2025 story unfolds, investors want clarity on growth, margins, and risk. This article brea...
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
ChangeNOW has unveiled Private Send, a new privacy feature in NOW Wallet that hides the direct link between sender an...